Preventing blood clots in advanced solid tumor cancer
Treatments studied
Part of Cancer, Heart & circulation, Lungs & breathing clinical trials.
This trial tests a new drug called REGN7508 to see if it can prevent dangerous blood clots in people with advanced or metastatic solid tumors. People with a higher risk of clots (based on a simple score or tumor genetics) may qualify.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed solid tumor cancer that is advanced or has spread
- You have a Khorana score of 2 or higher, or a tumor gene change linked to higher blood clot risk
- You are able to be up and about (ECOG 0-2)
- You do not have a bleeding disorder or high bleeding risk
- You do not have a primary brain tumor or brain metastases
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new anticoagulant medication to treat and prevent blood clots in patients with active cancer. You may qualify if you have a recent clot in your leg or lungs and are already taking a blood thinner.
This trial studies how your blood's ability to clot changes over time in people with certain cancers who have not yet started treatment. The goal is to better predict who might develop a dangerous blood clot, so that preventative steps can be taken.
This trial is testing a program to help prevent blood clots in people with cancer who are starting a new type of cancer treatment, like chemotherapy or targeted therapy. The goal is to see if better prevention strategies can keep you safe during treatment.
This study is for people with cancer who have had a serious blood clot. Researchers want to create a risk score that predicts who might have another clot or a bleeding problem from treatment, so they can better tailor care.
This Phase 3 study tests whether the medicine rivaroxaban can prevent dangerous blood clots in people with cancer who have a central venous catheter placed recently. It may help reduce clot risk while your catheter is in place, but you must meet safety and bleeding-risk criteria.
This trial tests a new drug, BTM-3566, for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective.
Hear when a new Cancer-Associated Thrombosis (CAT) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.